106 related articles for article (PubMed ID: 17436601)
41. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.
Nelson SM; Yates RW; Lyall H; Jamieson M; Traynor I; Gaudoin M; Mitchell P; Ambrose P; Fleming R
Hum Reprod; 2009 Apr; 24(4):867-75. PubMed ID: 19136673
[TBL] [Abstract][Full Text] [Related]
42. Use of a low dose of equine purified FSH to induce multiple ovulations in mares.
Araujo GH; Rocha Filho AN; Lopes EP; Moya CF; Alvarenga MA
Reprod Domest Anim; 2009 Jun; 44(3):380-3. PubMed ID: 18673335
[TBL] [Abstract][Full Text] [Related]
43. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
44. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
45. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
Bianchi V; Dal Prato L; Maccolini A; Mazzone S; Borini A
Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
[TBL] [Abstract][Full Text] [Related]
46. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
[TBL] [Abstract][Full Text] [Related]
47. [Effect of pelvic inflammatory disease grades on in vitro fertilization-embryo transfer outcome].
Yang XE; Zhang SY
Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):666-9. PubMed ID: 18241540
[TBL] [Abstract][Full Text] [Related]
48. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
49. The probability of successful IVF outcome after poor ovarian response.
Saldeen P; Källen K; Sundström P
Acta Obstet Gynecol Scand; 2007; 86(4):457-61. PubMed ID: 17486468
[TBL] [Abstract][Full Text] [Related]
50. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women.
Kaufmann R; Dunn R; Vaughn T; Hughes G; O'Brien F; Hemsey G; Thomson B; O'Dea LS
Clin Endocrinol (Oxf); 2007 Oct; 67(4):563-9. PubMed ID: 17692110
[TBL] [Abstract][Full Text] [Related]
51. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
52. Does 75 IU difference improve the cycle performance in poor responders? Comparison of daily 375 versus 450 IU gonadotrophin doses.
Dilbaz S; Demir B; Cinar O; Dede S; Aydin S; Beydilli G; Goktolga U
Gynecol Endocrinol; 2011 Dec; 27(12):1001-6. PubMed ID: 21500998
[TBL] [Abstract][Full Text] [Related]
53. Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study.
Barbosa CP; Cordts EB; Costa AC; de Oliveira R; de Mendonça MA; Christofolini DM; Bianco B
J Ovarian Res; 2014 Jan; 7():11. PubMed ID: 24447686
[TBL] [Abstract][Full Text] [Related]
54. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
[TBL] [Abstract][Full Text] [Related]
55. Mild ovarian stimulation for IVF.
Verberg MF; Macklon NS; Nargund G; Frydman R; Devroey P; Broekmans FJ; Fauser BC
Hum Reprod Update; 2009; 15(1):13-29. PubMed ID: 19091755
[TBL] [Abstract][Full Text] [Related]
56. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
Fisch JD; Keskintepe L; Sher G
Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
[TBL] [Abstract][Full Text] [Related]
57. Influence of ovarian hyperstimulation and ovulation induction on the cytoskeletal dynamics and developmental competence of oocytes.
Lee ST; Han HJ; Oh SJ; Lee EJ; Han JY; Lim JM
Mol Reprod Dev; 2006 Aug; 73(8):1022-33. PubMed ID: 16705709
[TBL] [Abstract][Full Text] [Related]
58. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
Mathur R; Kailasam C; Jenkins J
Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
[TBL] [Abstract][Full Text] [Related]
59. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
[TBL] [Abstract][Full Text] [Related]
60. Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916).
Safdarian L; Mohammadi FS; Alleyassin A; Aghahosseini M; Meysamie A; Rahimi E
Hum Reprod; 2007 Sep; 22(9):2449-54. PubMed ID: 17635844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
